Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial - Some crucial criticalities
- PMID: 37041659
- DOI: 10.1111/1471-0528.17489
Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial - Some crucial criticalities
Comment in
-
Authors' reply.BJOG. 2023 Dec;130(13):1698-1699. doi: 10.1111/1471-0528.17649. Epub 2023 Sep 5. BJOG. 2023. PMID: 37667648 No abstract available.
Comment on
-
Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial.BJOG. 2023 Feb;130(3):312-319. doi: 10.1111/1471-0528.17335. Epub 2022 Nov 15. BJOG. 2023. PMID: 36349391 Clinical Trial.
References
REFERENCES
-
- Page A-S, Verbakel JY, Verhaeghe J, Latul YP, Housmans S, Deprest J. Laser versus sham for genitourinary syndrome of menopause: a randomised controlled trial. BJOG. 2023;130(3):312-9.
-
- Salvatore S, Nappi RE, Zerbinati N, Calligaro A, Ferrero S, Origoni M, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric. 2014;17(4):363-9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
